Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prostate Cancer Prevention Trial With Quercetin and Genistein (QUERGEN)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by University of Hohenheim.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
University Hospital Tuebingen
Provision of study products: Quercegen Pharmaceuticals LLC
Information provided by (Responsible Party):
Stephan C. Bischoff, MD, Professor, University of Hohenheim
ClinicalTrials.gov Identifier:
NCT01538316
First received: February 20, 2012
Last updated: May 13, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)